510(k) K050415
K050415 is an FDA 510(k) premarket notification submitted by Impedimed Pty , Ltd. for the device "IMPEDIMED-EXTRACELLULAR FLUID ANALYSIS". The FDA issued a decision of Substantially Equivalent (kit) on March 30, 2007. The device falls under product code OBH (Monitor, Extracellular Fluid, Lymphedema, Extremity), a Class II device regulated under 21 CFR 870.2770. Impedimed Pty , Ltd. has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESK (Substantially Equivalent (kit))
- Decision Date
- March 30, 2007
- Date Received
- February 18, 2005
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Monitor, Extracellular Fluid, Lymphedema, Extremity
- Device Class
- Class II
- Regulation Number
- 870.2770
- Review Panel
- GU
- Submission Type
Measure impedances in affected and unaffected but opposite extremity to periodically monitor the level of extracellular fluid or the differences in bioimpedance between opposing extremities for patients who have been previously diagnosed with unilateral lymphedema (that is, in one affected extremity)